We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Immunomedics Inc in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 403 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 408 → 0 (-408)

100% less funds holding in top 10

Funds holding in top 10: 68 → 0 (-68)

100% less capital invested

Capital invested by funds: $17B → $0 (-$17B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 403

Holders
–
Holders Change
-408
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-68
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
403
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$2.23B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.54B
3
BlackRock
BlackRock
New York
-$1.14B
4
HI
HBK Investments
Texas
-$553M
5
FCM
Farallon Capital Management
California
-$498M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
301
Telemetry Investments
New York
– -$611K -7,191 Closed
BWCS
302
Beirne Wealth Consulting Services
Connecticut
– -$610K -7,174 Closed
CFD
303
Creative Financial Designs
Indiana
– -$580K -6,822 Closed
DTL
304
Dynamic Technology Lab
Singapore
– -$574K -6,755 Closed
IRF
305
IBM Retirement Fund
New York
– -$569K -6,691 Closed
SACTSONJ
306
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
– -$536K -6,300 Closed
FB
307
Fulton Bank
Pennsylvania
– -$509K -5,986 Closed
HighTower Advisors
308
HighTower Advisors
Illinois
– -$504K -5,930 Closed
CCM
309
Crabel Capital Management
California
– -$502K -5,900 Closed
AAM
310
Advisors Asset Management
Colorado
– -$495K -5,820 Closed
IA
311
IFP Advisors
Florida
– -$498K -5,750 Closed
FPS
312
Fieldpoint Private Securities
Connecticut
– -$485K -5,701 Closed
OC
313
Oppenheimer & Co
New York
– -$468K -5,500 Closed
AIG
314
American International Group
New York
– -$458K -5,388 Closed
GVAG
315
Great Valley Advisor Group
Delaware
– -$453K -5,332 Closed
PAIM
316
Punch & Associates Investment Management
Minnesota
– -$432K -5,080 Closed
WWM
317
Windsor Wealth Management
Indiana
– -$432K -4,912 Closed
AWA
318
Arete Wealth Advisors
Illinois
– -$408K -4,800 Closed
OCM
319
Ovata Capital Management
Hong Kong
– -$400K -4,700 Closed
Cambridge Investment Research Advisors
320
Cambridge Investment Research Advisors
Iowa
– -$394K -4,634 Closed
PGFC
321
Peapack-Gladstone Financial Corp
New Jersey
– -$383K -4,500 Closed
Manulife (Manufacturers Life Insurance)
322
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$370K -4,350 Closed
BFM
323
Boothbay Fund Management
New York
– -$366K -4,301 Closed
VCM
324
Vivaldi Capital Management
Illinois
– -$364K -4,280 Closed
Mitsubishi UFJ Asset Management
325
Mitsubishi UFJ Asset Management
Japan
– -$361K -4,245 Closed
11 12
13
14 15

IMMU Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2020, worth a combined $0 — down 100% from $17B a quarter earlier.

Sellers outnumbered buyers: 403 funds closed out of IMMU and 0 opened new positions — a net loss of 403 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.23B sold.

  • 0 institutional investors held Immunomedics Inc (IMMU) as of Q4 2020, down from 408 in Q3 2020.
  • Funds reported $0 of Immunomedics Inc stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Immunomedics Inc positions in Q4 2020 and 403 closed out, a net change of -403 holders.
  • The largest Immunomedics Inc seller in Q4 2020 was Avoro Capital Advisors, an estimated $2.23B sold.

Based on aggregated 13F filings for Q4 2020.